Biodegradable polylactide microspheres enhance specific immune response induced by Hepatitis B surface antigen

References

• Hilleman MR. Overview of the pathogenesis, prophylaxis and therapeusis of viral hepatitis B, with focus on reduction to practical applications. Vaccine 2001; 19:1837 - 48; http://dx.doi.org/10.1016/S0264-410X(00)00364-9; PMID: 11228353
   PubMed Web of Science ®Google Scholar
• Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995; 13:29 - 60; http://dx.doi.org/10.1146/annurev.iy.13.040195.000333; PMID: 7612225
   PubMed Web of Science ®Google Scholar
• Ishikawa T, Kono D, Chung J, Fowler P, Theofilopoulos A, Kakumu S, Chisari FV. Polyclonality and multispecificity of the CTL response to a single viral epitope. J Immunol 1998; 161:5842 - 50; PMID: 9834062
   PubMed Web of Science ®Google Scholar
• O’Hagan DT, Singh M. Microparticles as vaccine adjuvants and delivery systems. Expert Rev Vaccines 2003; 2:269 - 83; http://dx.doi.org/10.1586/14760584.2.2.269; PMID: 12899577
   PubMedGoogle Scholar
• Eldridge JH, Staas JK, Meulbroek JA, Tice TR, Gilley RM. Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies. Infect Immun 1991; 59:2978 - 86; PMID: 1879922
   PubMed Web of Science ®Google Scholar
• Shen H, Ackerman AL, Cody V, Giodini A, Hinson ER, Cresswell P, Edelson RL, Saltzman WM, Hanlon DJ. Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles. Immunology 2006; 117:78 - 88; http://dx.doi.org/10.1111/j.1365-2567.2005.02268.x; PMID: 16423043
   PubMed Web of Science ®Google Scholar
• Men Y, Tamber H, Audran R, Gander B, Corradin G. Induction of a cytotoxic T lymphocyte response by immunization with a malaria specific CTL peptide entrapped in biodegradable polymer microspheres. Vaccine 1997; 15:1405 - 12; http://dx.doi.org/10.1016/S0264-410X(97)00047-9; PMID: 9302752
   PubMed Web of Science ®Google Scholar
• Otten G, Schaefer M, Greer C, Calderon-Cacia M, Coit D, Kazzaz J, Medina-Selby A, Selby M, Singh M, Ugozzoli M, et al. Induction of broad and potent anti-human immunodeficiency virus immune responses in rhesus macaques by priming with a DNA vaccine and boosting with protein-adsorbed polylactide coglycolide microparticles. J Virol 2003; 77:6087 - 92; http://dx.doi.org/10.1128/JVI.77.10.6087-6092.2003; PMID: 12719603
   PubMed Web of Science ®Google Scholar
• Zuñiga J, Torres-García D, Santos-Mendoza T, Rodriguez-Reyna TS, Granados J, Yunis EJ. Cellular and humoral mechanisms involved in the control of tuberculosis. Clin Dev Immunol 2012; 2012:193923; http://dx.doi.org/10.1155/2012/193923; PMID: 22666281
   PubMed Web of Science ®Google Scholar
• Lee WM. Hepatitis B virus infection. N Engl J Med 1997; 337:1733 - 45; http://dx.doi.org/10.1056/NEJM199712113372406; PMID: 9392700
   PubMed Web of Science ®Google Scholar
• Preis I, Langer RS. A single-step immunization by sustained antigen release. J Immunol Methods 1979; 28:193 - 7; http://dx.doi.org/10.1016/0022-1759(79)90341-7; PMID: 469267
   PubMed Web of Science ®Google Scholar
• Singh M, Li XM, McGee JP, Zamb T, Koff W, Wang CY, O’Hagan DT. Controlled release microparticles as a single dose hepatitis B vaccine: evaluation of immunogenicity in mice. Vaccine 1997; 15:475 - 81; http://dx.doi.org/10.1016/S0264-410X(97)00225-9; PMID: 9160514
   PubMed Web of Science ®Google Scholar
• Singh M, Li XM, Wang H, McGee JP, Zamb T, Koff W, Wang CY, O’Hagan DT. Immunogenicity and protection in small-animal models with controlled-release tetanus toxoid microparticles as a single-dose vaccine. Infect Immun 1997; 65:1716 - 21; PMID: 9125552
   PubMed Web of Science ®Google Scholar
• Gupta RK, Singh M, O’Hagan DT. Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines. Adv Drug Deliv Rev 1998; 32:225 - 46; http://dx.doi.org/10.1016/S0169-409X(98)00012-X; PMID: 10837646
   PubMed Web of Science ®Google Scholar
• Otten G, Schaefer M, Greer C, Calderon-Cacia M, Coit D, Kazzaz J, Medina-Selby A, Selby M, Singh M, Ugozzoli M, et al. Induction of broad and potent anti-human immunodeficiency virus immune responses in rhesus macaques by priming with a DNA vaccine and boosting with protein-adsorbed polylactide coglycolide microparticles. J Virol 2003; 77:6087 - 92; http://dx.doi.org/10.1128/JVI.77.10.6087-6092.2003; PMID: 12719603
   PubMed Web of Science ®Google Scholar
• Jaganathan KS, Vyas SP. Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally. Vaccine 2006; 24:4201 - 11; http://dx.doi.org/10.1016/j.vaccine.2006.01.011; PMID: 16446012
   PubMed Web of Science ®Google Scholar
• Thomas C, Rawat A, Hope-Weeks L, Ahsan F. Aerosolized PLA and PLGA nanoparticles enhance humoral, mucosal and cytokine responses to hepatitis B vaccine. Mol Pharm 2011; 8:405 - 15; http://dx.doi.org/10.1021/mp100255c; PMID: 21189035
   PubMed Web of Science ®Google Scholar
• Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell R, Chisari FV. Viral clearance without destruction of infected cells during acute HBV infection. Science 1999; 284:825 - 9; http://dx.doi.org/10.1126/science.284.5415.825; PMID: 10221919
   PubMed Web of Science ®Google Scholar
• Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber R, Chisari FV. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 1996; 4:25 - 36; http://dx.doi.org/10.1016/S1074-7613(00)80295-2; PMID: 8574849
   PubMed Web of Science ®Google Scholar
• Komatsu H, Inui A, Sogo T, Hiejima E, Tateno A, Klenerman P, Fujisawa T. Cellular immunity in children with successful immunoprophylactic treatment for mother-to-child transmission of hepatitis B virus. BMC Infect Dis 2010; 10:103; http://dx.doi.org/10.1186/1471-2334-10-103; PMID: 20423521
   PubMed Web of Science ®Google Scholar
• Tomazic-Jezic VJ, Merritt K, Umbreit TH. Significance of the type and the size of biomaterial particles on phagocytosis and tissue distribution. J Biomed Mater Res 2001; 55:523 - 9; http://dx.doi.org/10.1002/1097-4636(20010615)55:4<523::AID-JBM1045>3.0.CO;2-G; PMID: 11288080
   PubMed Web of Science ®Google Scholar
• Singh M, Briones M, Ott G, O’Hagan D. Cationic microparticles: A potent delivery system for DNA vaccines. Proc Natl Acad Sci U S A 2000; 97:811 - 6; http://dx.doi.org/10.1073/pnas.97.2.811; PMID: 10639162
   PubMed Web of Science ®Google Scholar
• Foged C, Brodin B, Frokjaer S, Sundblad A. Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. Int J Pharm 2005; 298:315 - 22; http://dx.doi.org/10.1016/j.ijpharm.2005.03.035; PMID: 15961266
   PubMed Web of Science ®Google Scholar
• Wei Q, Wei W, Lai B, Wang LY, Wang YX, Su ZG, Ma GH. Uniform-sized PLA nanoparticles: preparation by premix membrane emulsification. Int J Pharm 2008; 359:294 - 7; http://dx.doi.org/10.1016/j.ijpharm.2008.03.027; PMID: 18457929
   PubMed Web of Science ®Google Scholar
• Schirmbeck R, Melber K, Mertens T, Reimann J. Antibody and cytotoxic T-cell responses to soluble hepatitis B virus (HBV) S antigen in mice: implication for the pathogenesis of HBV-induced hepatitis. J Virol 1994; 68:1418 - 25; PMID: 8107205
   PubMed Web of Science ®Google Scholar